Joshua Reed

Currently holds a position at Aldeyra Therapeutics Inc

Position	Company	Period
Chief Financial Officer	Aldeyra Therapeutics Inc	July 27, 2018 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-07-06	2026-07-01	Scholar Rock Holding Corp (SRRK)	PlS Planned sale	7,295 +20.7% 334.84 US$4,515,135	7,295 +20.7%	334.84	US$4,515,135
2026-07-06	2026-07-01	Scholar Rock Holding Corp (SRRK)	PlS Planned sale	2,544 -8.6% 199.47 US$1,117,875	2,544 -8.6%	199.47	US$1,117,875
2026-07-01	2026-07-01	Scholar Rock Holding Corp (SRRK)	PrS Proposed sale	19,842 229.31 US$886,519	19,842	229.31	US$886,519
2025-05-30	2025-05-29	Scholar Rock Holding Corp (SRRK)	PlS Planned sale	500 -3.1% 30.04 US$15,022	500 -3.1%	30.04	US$15,022
2025-05-30	2025-05-29	Scholar Rock Holding Corp (SRRK)	PlS Planned sale	4,900 -23.2% 29.68 US$145,441	4,900 -23.2%	29.68	US$145,441
2025-05-29	2025-05-29	Scholar Rock Holding Corp (SRRK)	PrS Proposed sale	5,400 29.66 US$160,164	5,400	29.66	US$160,164
2019-09-09	2019-09-05	Aldeyra Therapeutics Inc (ALDX)	PP Planned purchase	3,200 +9.8% 4.71 US$15,072	3,200 +9.8%	4.71	US$15,072